[Prediction of treatment efficacy by the M-protein reduction rate after the first cycle of VAD therapy for multiple myeloma]. [electronic resource]
Producer: 20101116Description: 685-9 p. digitalISSN:- 0485-1439
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers -- blood
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- diagnosis
- Myeloma Proteins -- analysis
- Retrospective Studies
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: English Abstract; Journal Article
There are no comments on this title.
Log in to your account to post a comment.